In addition to mutations, genomic amplification of PIK3CA has been reported in various human cancers, including ovarian cancer, cervical cancer, thyroid cancer, and non-small cell lung cancer (NSCLC) [16-19]. Here, PIK3CA is linked to cervical cancer.